Bank Of Nova Scotia Bio Techne Corp Transaction History

Bank Of Nova Scotia

$56.9 Billion
Q2 2024

A detailed history of Bank Of Nova Scotia transactions in Bio Techne Corp stock. As of the latest transaction made, Bank Of Nova Scotia holds 11,819 shares of TECH stock, worth $944,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,819

Previous 16,373 27.81%

Holding current value

$944,456

Previous $1.15 Million 26.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $282,894 - $383,219	-4,554 Reduced 27.81%	11,819 $846,000
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $10,094 - $11,794	-153 Reduced 0.93%	16,373 $1.15 Million
Q4 2023 Feb 12, 2024	BUY	$52.83 - $78.22 $101,063 - $149,634	1,913 Added 13.09%	16,526 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $122,953 - $162,833	1,821 Added 14.24%	14,613 $994,000
Q2 2023 Aug 03, 2023	BUY	$73.76 - $85.98 $168,025 - $195,862	2,278 Added 21.67%	12,792 $1.04 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $304,385 - $368,135	4,250 Added 67.85%	10,514 $780,000
Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $430,213 - $1.88 Million	5,333 Added 572.82%	6,264 $519,000
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $2,542 - $3,526	-9 Reduced 0.96%	931 $264,000
Q2 2022 Aug 05, 2022	SELL	$322.67 - $449.65 $557,251 - $776,545	-1,727 Reduced 64.75%	940 $326,000
Q1 2022 May 09, 2022	SELL	$353.85 - $487.79 $2.54 Million - $3.5 Million	-7,167 Reduced 72.88%	2,667 $1.16 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $2.16 Million - $2.49 Million	4,735 Added 92.86%	9,834 $5.1 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $2.27 Million - $2.75 Million	5,099 New	5,099 $2.47 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.13B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Bio Techne Corp Transaction History